This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Stichting Sanquin Bloedvoorziening. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Jan Voorberg: Innovator in Hemophilia Treatment
Introduction
Jan Voorberg is a notable inventor based in Wormer, Netherlands. He has made significant contributions to the field of medicine, particularly in the treatment of bleeding disorders. His innovative approach focuses on the use of antibodies to improve patient outcomes for those suffering from conditions like Hemophilia A.
Latest Patents
Jan Voorberg holds a patent for a method of treating patients suffering from a bleeding disorder. This patent, titled "Method of treating a patient suffering from a bleeding disorder comprising administering an antibody against the A3-C1 of FVIII," outlines the use of peptides derived from and antibodies generated against Factor VIII. The invention aims to inhibit the interaction of Factor VIII with LRP, decrease its degradation, and prolong its half-life in biological fluids. This method is particularly beneficial for treating blood coagulation disorders, especially Hemophilia A.
Career Highlights
Throughout his career, Jan Voorberg has worked with prominent organizations such as Stichting Sanquin Bloedvoorziening and Baxter Healthcare SA. His work has been instrumental in advancing therapeutic strategies for blood coagulation disorders.
Collaborations
Jan has collaborated with notable professionals in his field, including Koenraad Mertens and Friedrich Scheiflinger. These collaborations have further enhanced his research and development efforts in the medical sector.
Conclusion
Jan Voorberg's innovative contributions to the treatment of bleeding disorders highlight his dedication to improving patient care. His patent and career achievements reflect his significant impact on the medical community.